{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:54:46Z","timestamp":1787007286671,"version":"build-2736575974"},"reference-count":109,"publisher":"Informa UK Limited","issue":"8","funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["#503\/1-156-04\/503-11-001"],"award-info":[{"award-number":["#503\/1-156-04\/503-11-001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2024,5,23]]},"DOI":"10.1080\/14656566.2024.2366993","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T10:38:27Z","timestamp":1718015907000},"page":"1039-1049","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome"],"prefix":"10.1080","volume":"25","author":[{"given":"Olga","family":"Biniszewska","sequence":"first","affiliation":[{"name":"Medical University of Lodz","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Jacenik","sequence":"additional","affiliation":[{"name":"University of Lodz","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Tarasiuk","sequence":"additional","affiliation":[{"name":"Medical University of Lodz","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Fichna","sequence":"additional","affiliation":[{"name":"Medical University of Lodz","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i34.12144"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.advms.2016.11.001"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i26.4120"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S40245"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2023.2223975"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01395503"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.5056\/jnm.2011.17.2.131"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i39.14126"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2010.12.011"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.1.91"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.035451"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13283"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6138.653"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.11.019"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.58931\/cpct.2023.1S0410"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.6"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.7.852"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03975.x"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.5056\/jnm16135"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20275"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10060412"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2007.00973.x"},{"issue":"7","key":"e_1_3_4_25_1","first-page":"1348","article-title":"Does routine abdominal ultrasound enhance diagnostic accuracy in irritable bowel syndrome?","volume":"91","author":"Francis CY","year":"1996","unstructured":"Francis CY, Duffy JN, Whorwell PJ, et al. Does routine abdominal ultrasound enhance diagnostic accuracy in irritable bowel syndrome? Am J Gastroenterol. 1996 Jul;91(7):1348\u20131350.","journal-title":"Am J Gastroenterol"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S12596"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.5056\/jnm18082"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-020-00760-8"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0694-z"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.08.010"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30217-X"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.255"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0157-5"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.255"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001334"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.295"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.14309\/00000434-201410002-01831"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1427733"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0026-7"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2020.1722101"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01634-7"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac963"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2008.07.008"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.22-24"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.84"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03881.x"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656560802631319"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.070789"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01372.x"},{"key":"e_1_3_4_50_1","unstructured":"Joint Meeting of the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committees; Fda.gov [Internet]. 2018 [cited 2024 Feb 16]. Available from: https:\/\/www.fda.gov\/media\/119011\/download"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871523018666190911121306"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i21.3771"},{"key":"e_1_3_4_53_1","unstructured":"Helpguide.org [Internet]. Los Angeles high-fiber foods. 2018 [cited 2024 Feb 16]. Available from: https:\/\/www.helpguide.org\/articles\/healthy-eating\/high-fiber-foods.htm"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu15071647"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0269-2813.2004.01862.x"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3154"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2005.10.003"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2015.03.064"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.6133\/apjcn.202003_29(1).0009"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu12010148"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02506.x"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13685"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311339"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.245"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2012.32063"},{"key":"e_1_3_4_66_1","volume-title":"Advances in food and nutrition research. Vol 68, Nutritional benefits of Kiwifruit","author":"Henare SJ","year":"2013","unstructured":"Henare SJ, Rutherfurd SM, editors. Chapter Five. Fiber: Composition, Structures, and Functional Properties. In Advances in food and nutrition research. Vol 68, Nutritional benefits of Kiwifruit. Palmerston North (NZ): Elsevier; 2013."},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1021\/jf903332a"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114513003401"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90177-f"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom10010014"},{"issue":"3","key":"e_1_3_4_71_1","first-page":"162","article-title":"Anthraquinones \u2013 small molecules, big expectancy","volume":"66","author":"Sobotta \u0141","year":"2010","unstructured":"Sobotta \u0141, Mielcarek J, Sobiak S, et al. Anthraquinones \u2013 small molecules, big expectancy. Farm Pol. 2010;66(3):162\u2013167.","journal-title":"Farm Pol"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.167270"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31817fadd6"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03750.x"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-017-0605-x"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12911"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1097\/MRM0000000000000284"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030685"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.13204"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05007.x"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2011.01803.x"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40312.x"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000987"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.070987"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.3920\/BM2020.0191"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i30.4012"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2020.04.063"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.3390\/foods8030092"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12393-020-09209-0"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-019-05695-3"},{"key":"e_1_3_4_91_1","unstructured":"Constipation Associated With Irritable Bowel Syndrome (IBS-C) ClinicalTrials.gov. [Internet] (MD): Norgine; 2008 [updated February 17 2010; cited 2024 Feb 16] Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT00796354"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.02.054"},{"key":"e_1_3_4_93_1","unstructured":"Effects of ROSE-010 on GI transit in constipation predominant irritable bowel syndrome (C-IBS) patients clinicalTrials.Gov. [Internet] (MD): Michael Camilleri Mayo Clinic; 2010 [updated 2013-05-31;cited 2024 Feb 16] Available from: https:\/\/clinicaltrials.gov\/study\/NCT01056107"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00076.2012"},{"key":"e_1_3_4_95_1","unstructured":"Olorinab in irritable bowel syndrome with predominant constipation (IBS-C) and irritable bowel syndrome with predominant diarrhea (IBS-D) ClinicalTrials.Gov. [Internet]. (MD): Arena Pharmaceuticals; 2019 [updated: 2022-10-12; cited 2024 Feb 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04043455"},{"key":"e_1_3_4_96_1","unstructured":"Use of novel prebiotic fiber for targeted dietary management of irritable bowel syndrome (Nutrabiotix Phase II) ClinicalTrials.Gov. [Internet]. (MD): Nutrabiotix LLC; 2014 [updated 2016-04; cited 2024 Feb 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02144753"},{"key":"e_1_3_4_97_1","unstructured":"Synthetic biologics discontinues study of SYN-010 in IBS-C patients. Am Pharm Rev [Internet]. 2020 [cited 2024 Feb 16] Available from: https:\/\/www.americanpharmaceuticalreview.com\/1315-News\/568916-Synthetic-Biologics-Discontinues-Study-of-SYN-010-in-IBS-C-Patients\/?catid=6262"},{"key":"e_1_3_4_98_1","unstructured":"Olorinab in irritable bowel syndrome with predominant constipation (IBS-C) and irritable bowel syndrome with predominant diarrhea (IBS-D) (CAPTIVATE) Maryland ClinicalTrials.Gov [Internet]. Marylan: Arena Pharmaceuticals; 2021 [updated: 2022 Oct 12; cited 2024 Feb 16]. Available from: https:\/\/clinicaltrials.gov\/\/study\/NCT04043455"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14539"},{"key":"e_1_3_4_100_1","unstructured":"Cheno effect on transit in health and IBS-C (Chenotransit) ClinicalTrials.Gov [Internet]. Marylan: Mayo Clinic; 2009 [update: 2012 Jul 02; cited 2024 Feb 16]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00912301"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.07.052"},{"key":"e_1_3_4_102_1","unstructured":"A safety and efficacy study of a range of linaclotide doses administered orally to children ages 7\u201317 years with irritable bowel syndrome with constipation (LIN-MD-63) ClinicalTrials.Gov [Internet]. (MD): Forest Laboratories; 2015 [update 2020 Dec 28; cited 2024 Feb 16]. Available from: https:\/\/tiny.pl\/dq7td"},{"key":"e_1_3_4_103_1","unstructured":"Trial of linaclotide in patients with irritable bowel syndrome with constipation (IBS-C) ClinicalTrails.Gov [Internet]. Marylan: Ironwood Pharmaceuticals Inc.; 2015 [update 2020 Apr 24; cited 2024 Feb 16]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT02559206"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001056"},{"key":"e_1_3_4_105_1","unstructured":"Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C ClinicalTrials.gov [Internet]. (MD): Allergan; 2019 [updated 2023 Oct 30; cited 2024 Feb 16]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04166058"},{"key":"e_1_3_4_106_1","unstructured":"Linaclotide safety and efficacy in pediatric participants 6 to 17 years of age with irritable bowel syndrome with constipation (IBS-C) or functional constipation (FC ClinicalTrials.Gov [Internet]. (MD): Allergan; 2019 [updated 2024 Jan 16; cited 2024 Feb 16]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04026113"},{"key":"e_1_3_4_107_1","unstructured":"Trial of linaclotide in patients with irritable bowel syndrome with constipation (IBS-C) ClinicalTrials.Gov [Internet]. (MD): Ironwood Pharmaceuticals; 2015 [updated 2016 Sept 30; cited 2024 Feb 16]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/\/NCT02559206"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.254"},{"key":"e_1_3_4_109_1","unstructured":"Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome ClinicalTrials.gov [Internet]. (MD): University Hospital of North Norway; 2021 [updated 2022 Oct 28; cited 2024 Feb 16]. Available from: https:\/\/tiny.pl\/dq7hf"},{"key":"e_1_3_4_110_1","unstructured":"Efficacy of tegaserod in relieving the symptoms of female patients with irritable bowel syndrome (IBS) excluding those with predominant diarrhea IBS. ClinicalTrials.gov [Internet]. (MD): Novartis; 2005 [updated 2008 Jan 28; cited 2024 Feb 16]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT00142987"},{"key":"e_1_3_4_111_1","unstructured":"A study of the effect of linaclotide on abdominal girth in participants with irritable bowel syndrome with constipation (IBS-C). ClinicalTrails.gov [Internet]. (MD): Ironwood Pharmaceuticals Inc; 2021 [cited 2024 Feb 16]. Available from: http:\/\/surl.li\/qogek"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2024.2366993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:08:53Z","timestamp":1738202933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2024.2366993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":109,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,5,23]]}},"alternative-id":["10.1080\/14656566.2024.2366993"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2024.2366993","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}